SCHEMBL8307763

SCHEMBL8307763

O=C1NC(=S)SC1=CCc1cccc(O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAT1 P18440 5/20 0.61
CISD1 Q9NZ45 2/20 0.54
PIM1 P11309 1/20 0.49
MEN1 O00255 1/20 0.48
NPC1 O15118 1/20 0.48
ALDH1A1 P00352 1/20 0.48
POLB P06746 1/20 0.48
HSP90AA1 P07900 1/20 0.48
MAPT P10636 1/20 0.48
RAB9A P51151 1/20 0.48
KMT2A Q03164 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
ADAMTS5 Q9UNA0 3/20 0.48
MMP13 P45452 2/20 0.48
MYC P01106 1/20 0.46
MAX P61244 1/20 0.46
MMP3 P08254 1/20 0.45
PTP4A3 O75365 3/20 0.45
CA2 P00918 1/20 0.44
EPHX1 P07099 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8713697 1.00 NAT1 (0.61) NAT1CISD1PIM1MEN1NPC1
SCHEMBL8171894 0.83 NAT1 (0.59) NAT1CISD1PIM1MEN1ALDH1A1
SCHEMBL18102998 0.83 NAT1 (0.59) NAT1CISD1PIM1MEN1ALDH1A1
SCHEMBL27479994 0.81 MEN1 (0.57) CISD1PIM1MEN1POLBKMT2A
SCHEMBL8714982 0.80 MMP13 (0.65) NAT1ADAMTS5MMP13MMP3PTP4A3
SCHEMBL8311453 0.80 MMP13 (0.65) NAT1ADAMTS5MMP13MMP3PTP4A3
SCHEMBL8708384 0.78 PIM1 (0.61) NAT1PIM1MEN1NPC1RAB9A
SCHEMBL8310456 0.78 PIM1 (0.61) NAT1PIM1MEN1NPC1RAB9A
SCHEMBL12892064 0.76 NAT1 (1.00) NAT1CISD1ADAMTS5MMP13MYC
SCHEMBL8310946 0.76 NAT1 (1.00) NAT1CISD1ADAMTS5MMP13MYC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0915090-A1 Compounds useful as hypoglycemic agents and for treating Alzheimer's disease ELI LILLY AND COMPANY (US) 1999-05-12 EP disclosed
US-5716975-A NONTOXIC RHODANINE DERIVATIVES; ANTIDIABETIC AGENTS, CATHEPSIN D INHIBITORS, B-AMYLOID PROTEIN REDUCTION ELI LILLY AND COMPANY (US) 1998-02-10 US disclosed
US-5661168-A ADMINISTERING RHODANINE DERIVATIVES TO CONTROL DIABETES ELI LILLY AND COMPANY (US) 1997-08-26 US disclosed
US-5523314-A RHODANINE DERIVATIVES ELI LILLY AND COMPANY (US) 1996-06-04 US disclosed
CN-1091006-A Chemical compound as blood sugar lowering and treatment degenerative brain disorder LILLY CO ELI (US) 1994-08-24 CN disclosed
EP-0587377-A2 Thiazolidinone derivatives as hypoglycemic agents and for treating Alzheimer's disease ELI LILLY AND COMPANY (US) 1994-03-16 EP disclosed